On Pharma Importadora, Exportadora E Distribuidora De Medicamentos Ltda.
Clinical trials sponsored by On Pharma Importadora, Exportadora E Distribuidora De Medicamentos Ltda., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New IVIG therapy V-IMMUNE tested in phase III trial for immune deficiency Results expected Sep 2026 (estimated)
-
New IVIG therapy V-IMMUNE tested in phase III trial for immune deficiency
Disease control Recruiting nowThis phase III trial tests V-IMMUNE, an intravenous immunoglobulin (IVIG) product, in about 50 people with primary immunodeficiency (PID). Participants, aged 2 and older, will switch from their current IVIG to V-IMMUNE every three weeks for a year. The study aims to see if V-IMMU…
Phase 3 • Sponsor: On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New IVIG treatment aims to boost platelets in bleeding disorder
Disease control Recruiting nowThis study tests whether V-IMMUNE, a human immunoglobulin given through a vein, can safely raise platelet counts in people with immune thrombocytopenia (ITP). About 31 adults and children aged 1 year and older with very low platelets will receive two daily infusions. The main goa…
Phase 3 • Sponsor: On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC